News | Artificial Intelligence | March 05, 2020

AI-Guided Ultrasound System Now Available in the U.S.

Caption Health is now accepting pre-orders for Caption AI, an FDA authorized AI-guided ultrasound system

Caption Health is now accepting pre-orders for Caption AI, the only FDA authorized AI-guided ultrasound system

March 5, 2020 — Caption Health, a medical AI company, announced that its flagship product, Caption AI, the first AI-guided medical imaging acquisition system, is now available for pre-order by healthcare providers. Caption AI is a transformational new technology that enables healthcare practitioners—even those without prior ultrasound experience — with the ability to perform ultrasound exams quickly and accurately, by providing expert guidance, automated quality assessment, and intelligent interpretation capabilities.

Caption AI comes equipped with Caption Guidance software, which uses artificial intelligence to provide real-time guidance and feedback on image quality to enable capture of diagnostic quality images. This announcement follows the recent groundbreaking marketing authorization of Caption Guidance software by the U.S. Food and Drug Administration (FDA). The safety and effectiveness of Caption Guidance was clinically validated in a multi-center prospective pivotal trial at Northwestern Medicine and Minneapolis Heart Institute at Allina Health with registered nurses with no prior ultrasound experience. Data on its effectiveness has been presented at conferences including the American Heart Association and the American Society of Echocardiography (ASE) Scientific Sessions. Full results of this study will be published in a peer-reviewed journal.

Caption AI also comes with FDA cleared automated interpretation capabilities. Caption Interpretation automatically reviews the clips from an exam, rates them according to image quality, and selects the best ones to calculate the patient's ejection fraction (EF), the most widely used measurement to assess cardiac function. The software was trained on a carefully curated dataset of over 4,000,000 images, representing 9,000 patients. Results from a study evaluating the effectiveness of Caption Interpretation were presented at the ASE Scientific Sessions, and concluded that the fully automated ejection fraction algorithm was accurate, performing well on patients across a range of body-mass index (BMI) and EF, including obese patients and on patients with a range of normal and abnormal EF.

Caption AI was developed to empower more clinicians with ultrasound image acquisition capability to bring the benefits of ultrasound to more patients, help standardize the quality of care, and help institutions realize valuable cost and time savings. The system is ideal for acute point-of-care settings, including emergency rooms, anesthesiology departments, and critical care units. In these environments, ultrasound can be used to triage, monitor, and assess patients who have chest pain, shortness of breath, cardiac arrest, and many other conditions, as well as for the detection of heart disease. Caption AI is a software solution that can be integrated onto compatible ultrasound devices and is offered through a subscription pricing model. Caption Health is now offering pre-orders of Caption AI to accredited United States healthcare providers for use with adult patients for delivery in Q3. Visit captionhealth.com to pre-order.

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
An estimated 44 million people worldwide are currently living with Alzheimer’s disease, the most common form of dementia. About 5.8 million people in the United States live with the disease, where it is the sixth leading cause of death overall. While there is not yet a cure for Alzheimer’s, researchers are working to find treatment options to delay its onset and prevent it from developing.

Image courtesy of Insightec

Feature | Ultrasound Imaging | April 02, 2020 | By Katie Caron
An estimated 44 million people worldwide are currently living with...
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

News | Ultrasound Imaging | April 02, 2020
April 2, 2020 — Esaote, an Italian company among the world leader
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once
News | Artificial Intelligence | April 02, 2020
April 2, 2020 — In the face of the COVID-19 pand
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — Lung infections generated by the coronavirus can be detected in...